Quality of opioid prescribing in older adults with or without Alzheimer disease and related dementia.
Alzheimer’s disease and related dementias
Inappropriate prescribing
Prescription opioids
Journal
Alzheimer's research & therapy
ISSN: 1758-9193
Titre abrégé: Alzheimers Res Ther
Pays: England
ID NLM: 101511643
Informations de publication
Date de publication:
12 04 2021
12 04 2021
Historique:
received:
08
08
2020
accepted:
26
03
2021
entrez:
22
4
2021
pubmed:
23
4
2021
medline:
25
6
2021
Statut:
epublish
Résumé
Pain is common among individuals with Alzheimer's disease and related dementias (ADRD), and use of opioids has been increasing over the last decade. Yet, it is unclear to what extent opioids are appropriately prescribed for patients with ADRD and whether the appropriateness of opioid prescribing differs by ADRD status. The objective of this study is to compare the quality of opioid prescribing among patients with or without ADRD who have chronic noncancer pain. A nationally representative cohort study of Medicare beneficiaries aged 50 years or older who had chronic pain but who had no cancer, hospice, or palliative care from 2011 to 2015. Four indicators of potentially inappropriate opioid prescribing were measured in patients residing in communities (75,258 patients with and 435,870 patients without ADRD); five indicators were assessed in patients in nursing homes (NHs) (37,117 patients with and 5128 patients without ADRD). Each indicator was calculated as the proportion of eligible patients with inappropriate opioid prescribing in the year after a chronic pain diagnosis. Differences in proportions between ADRD and non-ADRD groups were estimated using a generalized linear model adjusting for covariates through inverse probability weighting. Patients with ADRD versus those without had higher concurrent use of opioids and central nervous system-active drugs (community 44.1% vs 33.3%; NH 58.8% vs 54.1%, both P < 0.001) and no opioids or scheduled pain medications for moderate or severe pain (NH 60.1% vs 52.5%, P < 0.001). The ADRD versus non-ADRD group had higher use of long-term opioids for treating neuropathic pain in communities (21.7% vs 19.5%, P = 0.003) but lower use in NHs (26.9% vs 36.0%, P < 0.001). Use of strong or high-dose opioids when naive to opioids (community 1.5% vs 2.8%; NH 2.5% vs 3.5%) and use of contraindicated opioids (community 0.08% vs 0.12%; NH 0.05% vs 0.21%) were rare for either group. Potential inappropriate opioid prescribing in 2 areas of pain care was more common among patients with ADRD than among patients without ADRD in community or NH settings. Further studies aimed at understanding the factors and effects associated with opioid prescribing patterns that deviate from guidelines are warranted.
Sections du résumé
BACKGROUND
Pain is common among individuals with Alzheimer's disease and related dementias (ADRD), and use of opioids has been increasing over the last decade. Yet, it is unclear to what extent opioids are appropriately prescribed for patients with ADRD and whether the appropriateness of opioid prescribing differs by ADRD status. The objective of this study is to compare the quality of opioid prescribing among patients with or without ADRD who have chronic noncancer pain.
METHODS
A nationally representative cohort study of Medicare beneficiaries aged 50 years or older who had chronic pain but who had no cancer, hospice, or palliative care from 2011 to 2015. Four indicators of potentially inappropriate opioid prescribing were measured in patients residing in communities (75,258 patients with and 435,870 patients without ADRD); five indicators were assessed in patients in nursing homes (NHs) (37,117 patients with and 5128 patients without ADRD). Each indicator was calculated as the proportion of eligible patients with inappropriate opioid prescribing in the year after a chronic pain diagnosis. Differences in proportions between ADRD and non-ADRD groups were estimated using a generalized linear model adjusting for covariates through inverse probability weighting.
RESULTS
Patients with ADRD versus those without had higher concurrent use of opioids and central nervous system-active drugs (community 44.1% vs 33.3%; NH 58.8% vs 54.1%, both P < 0.001) and no opioids or scheduled pain medications for moderate or severe pain (NH 60.1% vs 52.5%, P < 0.001). The ADRD versus non-ADRD group had higher use of long-term opioids for treating neuropathic pain in communities (21.7% vs 19.5%, P = 0.003) but lower use in NHs (26.9% vs 36.0%, P < 0.001). Use of strong or high-dose opioids when naive to opioids (community 1.5% vs 2.8%; NH 2.5% vs 3.5%) and use of contraindicated opioids (community 0.08% vs 0.12%; NH 0.05% vs 0.21%) were rare for either group.
CONCLUSION
Potential inappropriate opioid prescribing in 2 areas of pain care was more common among patients with ADRD than among patients without ADRD in community or NH settings. Further studies aimed at understanding the factors and effects associated with opioid prescribing patterns that deviate from guidelines are warranted.
Identifiants
pubmed: 33883028
doi: 10.1186/s13195-021-00818-3
pii: 10.1186/s13195-021-00818-3
pmc: PMC8061026
doi:
Substances chimiques
Analgesics, Opioid
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
78Subventions
Organisme : NIA NIH HHS
ID : K01 AG054764
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG022845
Pays : United States
Organisme : NIA NIH HHS
ID : K01AG054764
Pays : United States
Références
J Gerontol A Biol Sci Med Sci. 2019 Nov 13;74(12):1910-1915
pubmed: 30561526
JAMA Neurol. 2017 Jul 1;74(7):773-779
pubmed: 28531306
JAMA. 2016 Apr 19;315(15):1624-45
pubmed: 26977696
BMC Geriatr. 2015 Apr 19;15:49
pubmed: 25928621
Pain Manag Nurs. 2010 Dec;11(4):209-23
pubmed: 21095596
Pain Med. 2019 Jun 1;20(Suppl 1):S2-S12
pubmed: 31152178
J Am Geriatr Soc. 2009 Aug;57(8):1331-46
pubmed: 19573219
Gerontologist. 2009 Dec;49(6):727-35
pubmed: 19531805
Am J Geriatr Psychiatry. 2016 Nov;24(11):949-963
pubmed: 27567185
JAMA Intern Med. 2017 Apr 1;177(4):583-585
pubmed: 28192559
Subst Abus. 2017 Jan-Mar;38(1):22-25
pubmed: 27925868
Pain. 2010 Aug;150(2):332-339
pubmed: 20554392
BMC Geriatr. 2006 Apr 03;6:7
pubmed: 16584565
Int J Geriatr Psychiatry. 2017 Feb;32(2):164-174
pubmed: 26889640
Int J Geriatr Psychiatry. 2013 Oct;28(10):1077-85
pubmed: 23348866
JAMA. 2017 Nov 28;318(20):2040-2042
pubmed: 29183059
J Am Geriatr Soc. 2015 Nov;63(11):2227-46
pubmed: 26446832
Health Care Financ Rev. 2002 Summer;23(4):5-18
pubmed: 12500467
Neuropsychiatr Dis Treat. 2018 May 09;14:1211-1220
pubmed: 29785112
Arch Intern Med. 2010 Sep 13;170(16):1425-32
pubmed: 20837827
Med Care. 2016 Nov;54(11):e73-e77
pubmed: 25625654
Curr Clin Pharmacol. 2015;10(3):194-203
pubmed: 26338172
J Pain Symptom Manage. 2008 Apr;35(4):388-96
pubmed: 18280101
Alzheimers Dement (N Y). 2018 Dec 07;4:661-668
pubmed: 30560199
Stat Methods Med Res. 2012 Feb;21(1):31-54
pubmed: 21030422
BMJ. 2015 Feb 13;350:h532
pubmed: 25680884
Pain Med. 2019 Jan 1;20(1):50-57
pubmed: 29136228
Alzheimer Dis Assoc Disord. 2017 Oct-Dec;31(4):315-321
pubmed: 28486239
Qual Life Res. 2017 Mar;26(3):685-693
pubmed: 28000094
Med Care. 2007 Oct;45(10 Supl 2):S103-7
pubmed: 17909367
Drugs Aging. 2011 Apr 1;28(4):283-93
pubmed: 21428463
Pain Rep. 2019 Dec 25;5(1):e803
pubmed: 32072098
J Am Geriatr Soc. 2012 Apr;60(4):616-31
pubmed: 22376048
Pain. 2017 Jun;158(6):1091-1099
pubmed: 28267065
BMC Geriatr. 2016 Jun 17;16:124
pubmed: 27317390
BMC Fam Pract. 2018 Oct 10;19(1):166
pubmed: 30301471
BMC Geriatr. 2016 Jul 11;16:137
pubmed: 27400744
JAMA. 1999 Oct 20;282(15):1458-65
pubmed: 10535437
Pol Arch Med Wewn. 2009 Jul-Aug;119(7-8):469-77
pubmed: 19776687
BMJ. 2005 Feb 26;330(7489):461-4
pubmed: 15731144
J Am Geriatr Soc. 2017 Sep;65(9):2052-2056
pubmed: 28467623
Health Soc Care Community. 2016 May;24(3):270-82
pubmed: 25708056
BMJ. 2010 Aug 05;341:c3584
pubmed: 20688840
Alzheimers Dement. 2015 Jun;11(6):691-9
pubmed: 25239738
Int J Palliat Nurs. 2015 Oct;21(10):479-87
pubmed: 26505082
J Am Geriatr Soc. 2020 Apr;68(4):794-802
pubmed: 31868921
Geriatr Gerontol Int. 2014 Jul;14(3):541-8
pubmed: 24020433
Int J Geriatr Psychiatry. 2006 Sep;21(9):824-30
pubmed: 16955439
Int J Geriatr Psychiatry. 2019 Feb;34(2):280-288
pubmed: 30370943
J Am Geriatr Soc. 2007 Oct;55(10):1508-16
pubmed: 17727648
World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253
pubmed: 11234459
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941